Intrinsic Value of S&P & Nasdaq Contact Us

Lite Strategy, Inc. LITS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
50/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Lite Strategy, Inc. (LITS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

Analysts estimate Earnings Per Share (EPS) of $3.62 and revenue of $0.07B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $2.67 vs est $3.62 (missed -26.2%). 2025: actual $-2.39 vs est $-6.28 (beat +61.9%). Analyst accuracy: 1%.

EPS Estimates — LITS

1%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $2.67 vs Est $3.62 ▼ 35.6% off
2025 Actual –$2.39 vs Est –$6.28 ▲ 162.8% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.

Revenue Estimates — LITS

100%
Analyst Accuracy
Accurate
1 year compared
Actual vs Estimate
2024 Actual $0.065B vs Est $0.065B ▼ 0.0% off
Revenue Trend
Revenue has declined over the period shown. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message